General Information of the Compound
Compound ID |
CP0751077
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-4-((S)-1-{[(S)-1-({[(S)-1-((S)-1-Carbamoyl-3-methylsulfanyl-propylcarbamoyl)-3-methyl-butylcarbamoyl]-methyl}-carbamoyl)-2-phenyl-ethyl]-methyl-carbamoyl}-2-phenyl-ethylcarbamoyl)-4-(oxalyl-amino)-butyric acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C39H53N7O11S
|
||||||||||||||||||
Molecular Weight |
827.958
|
||||||||||||||||||
Canonical SMILES |
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)C(=O)O)C(N)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C39H53N7O11S/c1-23(2)19-28(35(52)43-26(33(40)50)17-18-58-4)42-31(47)22-41-36(53)30(21-25-13-9-6-10-14-25)46(3)38(55)29(20-24-11-7-5-8-12-24)45-34(51)27(15-16-32(48)49)44-37(54)39(56)57/h5-14,23,26-30H,15-22H2,1-4H3,(H2,40,50)(H,41,53)(H,42,47)(H,43,52)(H,44,54)(H,45,51)(H,48,49)(H,56,57)/t26-,27-,28-,29-,30-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
GRMREWPIXQSXKU-IIZANFQQSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04126, Neuromedin-K receptor
Protein ID: PT01199, Neuromedin-K receptor
Protein ID: PT01290, Substance-K receptor
Protein ID: PT01410, Substance-P receptor